VALIDATION OF NEUROTENSIN TETRA-BRANCHED PEPTIDES AS TUMOR TARGETING AGENTS IN PANCREAS, COLON AND BLADDER CARCINOMA
Submitted: 16 May 2012
Accepted: 16 May 2012
Published: 16 May 2012
Accepted: 16 May 2012
Abstract Views: 683
PDF: 894
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Ravenni, N., Lelli, B., Brunetti, J., Falciani, C., Depau, L., Bencini, L., Minervini, A., Moretti, R., Carini, M., & Bracci, L. (2012). VALIDATION OF NEUROTENSIN TETRA-BRANCHED PEPTIDES AS TUMOR TARGETING AGENTS IN PANCREAS, COLON AND BLADDER CARCINOMA. Journal of the Siena Academy of Sciences, 2(1), 57. https://doi.org/10.4081/jsas.2010.490
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.